Clinical Trial Update: Acetyl-l-carnitine to Enhance Nerve Regeneration in Carpal Tunnel Syndrome [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on acetyl-L-carnitine for nerve regeneration in carpal tunnel syndrome. The Phase 2 and Phase 3 trials have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carpal Tunnel Syndrome
• Compression Neuropathy

Drugs mentioned

• Acetyl-L-carnitine (N-acetyl-L-carnitine)

Snippet

Sponsor: University of Alberta | Conditions: Carpal Tunnel Syndrome, Compression Neuropathy | Phase 2, Phase 3 | Status: COMPLETED